affect severity and outcome of degenerative cervical myelopathy
mogamulizumab (anti-ccr4) in htlv-1–associated myelopathy
mogamulizumab (anti-ccr4) in htlv-1–associated myelopathy
laminectomy without fusion for cervical spondylotic myelopathy
cervical myelopathy in rheumatoid arthritis英文文献资料.doc 8页